Genscript Biotech (GNNSF) News Today C$1.38 -0.01 (-1.01%) (As of 11/20/2024 03:29 PM ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy DevelopmentNovember 21 at 10:46 AM | prnewswire.comGenscript Biotech Aligns Interests with Restricted Share GrantNovember 19 at 5:16 PM | markets.businessinsider.comGenscript Biotech Strikes Lucrative Licensing DealNovember 15, 2024 | markets.businessinsider.comGenscript Reports on Legend Biotech’s Q3 FinancialsNovember 14, 2024 | markets.businessinsider.comGenScript Biotech Sets Up New Operations and Logistics Hub in Sydney, AustraliaNovember 10, 2024 | prnewswire.comGenscript Biotech’s CARVYKTI Shows Promise in Myeloma TreatmentNovember 7, 2024 | markets.businessinsider.comGenscript Biotech Announces Deconsolidation of Legend BiotechOctober 22, 2024 | markets.businessinsider.comGenScript Biotech Advances Sustainable Development with MSCI ESG Rating Upgrade to AOctober 11, 2024 | tmcnet.comGenscript Biotech Corp (GNNSF) (H1 2024) Earnings Call Highlights: Robust Revenue Growth Amidst ...October 10, 2024 | finance.yahoo.comGenscript Biotech Corporation (GNNSF)August 18, 2024 | finance.yahoo.comGenScript Biotech Corporation (GNNSF) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | seekingalpha.comGenScript Biotech Reports First Half 2024 ResultsAugust 9, 2024 | prnewswire.comGenscript Biotech (OTC:GNNSF) Stock Quotes, Forecast and News SummaryAugust 1, 2024 | benzinga.comGenScript Biotech Corporation Launches FLASH Gene Service: The Fastest and Most Affordable Gene Synthesis Solution on the MarketJune 18, 2024 | prnewswire.comGenScript Biotech Shares Drop After U.S. Lawmakers Scrutinize Chinese TiesJune 3, 2024 | wsj.comUS lawmakers ask FBI for briefing on GenScript Biotech's links to ChinaMay 31, 2024 | reuters.comGNNSF Genscript Biotech CorporationMay 25, 2024 | seekingalpha.comGenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic ApplicationsMay 13, 2024 | prnewswire.comMultiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy ManufacturingApril 25, 2024 | businesswire.comGenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future BlueprintApril 24, 2024 | finance.yahoo.comMultiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy ManufacturingApril 23, 2024 | prnewswire.comGenScript Biotech officially joins SBTi to fulfill its sustainability commitmentApril 15, 2024 | prnewswire.comGenScript Biotech Receives EcoVadis Bronze Medal for Outstanding Sustainability PerformanceMarch 26, 2024 | finance.yahoo.comGenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%March 12, 2024 | prnewswire.comGenscript Biotech GAAP EPS of -$4.53, revenue of $839.5M misses by $460.5MMarch 11, 2024 | msn.comDr. David Liu Joins GenScript's Scientific Advisory Board to Guide Company's Innovation StrategyMarch 8, 2024 | finance.yahoo.comImmunotherapy Pioneer Carl H. June, MD, Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy in Advancing Cell and Gene Therapy BreakthroughsMarch 6, 2024 | finance.yahoo.comWeek In Review: AlphaGen And ArtBio Form China-U.S. Radioligand PartnershipFebruary 25, 2024 | seekingalpha.comGenScript Announces Its Inaugural Life Science Research Grant ProjectFebruary 5, 2024 | finance.yahoo.comJefferies Reaffirms Their Buy Rating on Genscript Biotech (GNNSF)January 8, 2024 | markets.businessinsider.comGenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT IndustryJanuary 4, 2024 | finance.yahoo.comGenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare SectorJanuary 4, 2024 | finance.yahoo.comFDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene TherapyDecember 24, 2023 | finance.yahoo.comGenscript Biotech Corporation - Class H (GNNSF)December 19, 2023 | nasdaq.comGenScript to Host Biotech Global Forum 2024 during 42nd Annual J.P. Morgan Healthcare ConferenceDecember 14, 2023 | finance.yahoo.comGenScript Named a BioSpace 2024 Best Place to WorkDecember 1, 2023 | finance.yahoo.comGenScript ProBio Signs Viral Vector Manufacturing MOU With Curocell for Next-Generation CAR-T TherapyNovember 10, 2023 | businesswire.comGenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles FormulationSeptember 18, 2023 | finance.yahoo.comGenScript Biotech expands peptide production at Zhenjiang facilityAugust 10, 2023 | msn.comGenScript Biotech and T-MAXIMUM Biotech Form Strategic Alliance on cGMP sgRNAAugust 9, 2023 | finance.yahoo.comGenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIsAugust 8, 2023 | finance.yahoo.comGenScript to Host Third Annual Gene & Cell Engineering Virtual SummitJuly 20, 2023 | finance.yahoo.comGenScript Doubles cGMP sgRNA and Non-Viral DNA Payload Manufacturing CapacityJuly 6, 2023 | finance.yahoo.comGenScript Debuts AmMag™ Quatro to Revolutionize Automated Plasmid Maxi-Prep PurificationJune 20, 2023 | finance.yahoo.comGenScript Debuts GenTitan Gene Fragments Service to Expedite Gene Synthesis at Lower CostMay 23, 2023 | finance.yahoo.comGenScript to Debut Expanded Synthetic Biology Product Line at SynBioBeta 2023May 22, 2023 | finance.yahoo.comGenScript Expands Peptide and Oligonucleotide Production Facility in ChinaMay 18, 2023 | finance.yahoo.comGenscript Biotech Corporation - Class H (HKHKSG:1548) Price Target Decreased by 12.03% to 32.06April 25, 2023 | msn.comGenScript ProBio Enters Strategic Collaboration with Hibiocy Co. Ltd, the affiliate of Rojukiss International Public Company Limited (KISS) - the leading Thai-based Beauty & Health company, for the development and manufacturing of COVITRAP™ and future new products.October 17, 2022 | finance.yahoo.comGenScript and Gladstone-UCSF Institute of Genomic Immunology Collaborate on Groundbreaking Non-Viral Cell Therapy StudySeptember 22, 2022 | finance.yahoo.com Get Genscript Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for GNNSF and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] GNNSF Media Mentions By Week GNNSF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNNSF News Sentiment▼-0.100.47▲Average Medical News Sentiment GNNSF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNNSF Articles This Week▼30▲GNNSF Articles Average Week Get Genscript Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for GNNSF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ASPHF News Today ASCLF News Today AVCTF News Today AWKNF News Today AXIM News Today BRRGF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GNNSF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genscript Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genscript Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
